Ted Price, PhD (Co-Chair)
University of Texas at Dallas
Ted Price, PhD, performs research focused on molecular mechanisms driving the transition to chronic pain with an increasing focus on drug development for chronic pain disease modification.
Bob Dworkin, PhD (Co-chair)
University of Rochester
The primary focus of Dr. Dworkin’s current research involves methodologic aspects of analgesic clinical trials, especially identifying factors that might increase the assay sensitivity of a trial to detect differences between an active and a control or comparison treatment.
Jackie Bresnehan, PhD
University of California San Francisco
Dr. Bresnahan's research focuses on understanding the biological underpinnings of neurotrauma, particularly spinal cord injury, with the goal of improving recovery for individuals who suffer damage to the nervous system.
Jan Chambers *
National Fibromyalgia & Chronic Pain Association
Jan Favero Chambers is president of the National Fibromyalgia & Chronic Association (NFMCPA), a not for profit, 501c3 organization whose mission is to build a united patient and medical community that will execute advocacy programs regarding access to care, scientific research, diagnosis and treatment for people suffering with fibromyalgia and chronic pain.
Yves De Koninck, PhD
Dr. De Koninck Studies nervous signal transmission using state of the art techniques with the aim of alleviating chronic pain.
Ru-Rong Ji, PhD
Ru-Rong has been doing pain and neuroscience research for more than 20 years. His current research focuses on chronic pain mechanisms and development of novel pain therapeutics.
Joel Katz, PhD
Dr. Katz’s research is focused on assessing the contribution of peripheral injury to the development of pathological pain states in which the central nervous system plays a prominent role. He is also interested in designing and systematically evaluating means of preventing the state of central neural sensitization that develops after injury and that often marks the transition from time-limited pain to chronic pathological pain.
Annemieke Kavelaars, PhD
University of Texas, MD Anderson
Dr. Kavelaar’s work is focused on the broad field of nervous system-immune system interactions. Her most recent studies aim at understanding the endogenous neuroimmune mechanisms that govern resolution of pain.
Jon Levine MD, PhD
University of California San Francisco
Dr. Levine’s research focuses include Signal Transduction and Second Messenger Signaling in Pain Sensory Neurons; CNS Pain Control Mechanisms; Neural-Endocrine Control of Inflammation.
Neil Schechter, MD
Boston Children’s Hospital
Dr. Schechter’s research focus has been primarily on common pain problems in pediatric practice, functional pain, hypermobility syndromes, and strategies to promote institutional change regarding pain.
Kathleen Sluka, PT PhD
University of Iowa
Professor of Physical Therapy and Rehabilitation Science
Kathleen Sluka, PT, PhD, FAPTA is a Professor of Physical Therapy and Rehabilitation Science at the University of Iowa. Dr. Sluka’s lab studies the peripheral and central mechanisms of chronic musculoskeletal pain, and non-pharmacological treatment for chronic pain.
Greg Terman, MD
University of Washington
His research focuses on neuroplasticity associated with pain and opioids - including mechanisms of central sensitization, opiate tolerance, itch and respiratory depression. Although his research has been primarily pre-clinical, including slice physiology and behavioral pharmacology, he has also been involved in clinical studies in human volunteers and patients.
Tor Wager, PhD
University of Colorado
The Wager lab’s research focuses on the brain mechanisms underlying pain, emotion, and stress. The lab’s research emphasizes developing brain markers for these affective processes and using them to understand the effects of psychological and pharmacological interventions, including effects of placebo, expectancy, self-regulation, and opioids. Dr. Wager is also actively involved in developing new analysis methods for human neuroimaging and other complex multivariate datasets.
Tony Yaksh, PhD
University of California San Diego
The goal of my work is to understand the encoding process for nociceptive information to permit development of pharmacological therapies for the management of pain. A continuing thread of this ongoing work (>200 papers) has been the contribution of neuraxial innate immune signaling and the cascades that mediate the transition from an acute inflammation to a chronic neuropathic like pain state.
Audrey Kusiak, PhD (non-voting member)
VA representative to IPRCC
Martha Matocha, PhD (non-voting member)
NIH Pain Consortium
Khara Ramos, PhD (non-voting member)